Zhuojia Lin
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Retraction Notice to: Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling.
Journal: Molecular therapy. Nucleic acids
Published: December 26, 2022
miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.
Journal: Molecular therapy. Nucleic acids
Published: November 11, 2017
Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling.
Journal: Molecular therapy. Nucleic acids
Published: October 31, 2017
Inflammatory factor receptor Toll-like receptor 4 controls telomeres through heterochromatin protein 1 isoforms in liver cancer stem cell.
Journal: Journal of cellular and molecular medicine
Published: August 11, 2017
Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
Journal: Cell death & disease
Published: August 11, 2017
HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.
Journal: Oncotarget
Published: October 07, 2016
Inflammatory cytokine IL6 cooperates with CUDR to aggravate hepatocyte-like stem cells malignant transformation through NF-κB signaling.
Journal: Scientific reports
Published: March 24, 2016
Inflammatory related gene IKKα, IKKβ, IKKγ cooperates to determine liver cancer stem cells progression by altering telomere via heterochromatin protein 1-HOTAIR axis.
Journal: Oncotarget
Published: March 01, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026